Global Hepatitis C Virus Drug Market Research Report and Forecasts to 2018

1
Hepatitis C Market Forecast, HCV Drugs Clinical
Trials, Hepatitis C Pipeline Drugs Sales
Forecast WorldwidebyRenub Research
Published Jul 2013 No of Pages 164 Single
User PDF US 1290 Corporate User PDF US 2090

• View Complete Report _at_ http//www.lifescienceindus
  tryresearch.com/hepatitis-c-market-forecast-hcv-dr
  ugs-clinical-trials-hepatitis-c-pipeline-drugs-sal
  es-forecast-worldwide.html .

2
Hepatitis C Market Forecast, HCV Drugs Clinical
Trials, Hepatitis C Pipeline Drugs Sales
Forecast Worldwide
Hepatitis C market by 2018 is expected to grow
more than 3 times from its current market size of
2012. Hepatitis C virus (HCV) infection is a
complex public health problem, characterized by a
high prevalence of chronic infection, an
increasing burden of HCV-associated disease, low
rates of testing, treatment and the prospect of
increasing incidence associated with the epidemic
of injection drug use. Hepatitis C is a leading
cause of chronic liver disease, end-stage
cirrhosis and liver cancer. Because of the slow
progression and asymptomatic character of the
infection, many people are unaware of having it.
As a consequence, the infection is often
diagnosed at a late stage when treatment options
are limited. As no effective vaccine against the
Hepatitis C virus (HCV) has been discovered so
far the market is driven by therapeutics. The
increase in the prevalence of the disease and the
availability of new first-in-class therapies with
better safety and efficacy profiles are expected
to drive the growth of the HCV market. The growth
in HCV drugs market is primarily attributed to
high unmet need in the market which is expected
to be fulfilled by strong pipeline candidates.
Low levels of awareness and knowledge about HCV
have been identified as a formidable challenge to
prevention and care.
Buy a Copy of this Report _at_ http//www.lifescience
industryresearch.com/purchase?rname14764 .
3
Hepatitis C Market Forecast, HCV Drugs Clinical
Trials, Hepatitis C Pipeline Drugs Sales
Forecast Worldwide

• Hepatitis C Market Forecast, HCV Drugs
  Clinical Trials, Hepatitis C Pipeline Drugs Sales
  Forecast Worldwide provides a comprehensive
  assessment of the fast-evolving, high-growth of
  Hepatitis sector. This 164 page report with 25
  Figures and 2 Tables studies the Hepatitis C Drug
  Market Landscape. This report contains 7
  chapters.
• Hepatitis C Drugs Market Forecast (Chapter 2)
• Hepatitis C Approved Drugs Sales Forecast
  (Chapter 3)
• Hepatitis C Deals Acquisitions (Chapter 4)
• Hepatitis C Pipeline Drugs Clinical Trials
  (Drugs in Phase III) (Chapter 5)
• Hepatitis C Pipeline Drugs Clinical Trials
  (Drugs in Phase II) (Chapter 6)
• Hepatitis C Pipeline Drugs Sales Forecast
  (Chapter 7)
• Hepatitis C Approved Drugs sales Forecast
  Analysis (To 2016) (Chapter No. 3)
• Pegasys
• Pegintron
• Incivek
• Victrelis

4
Hepatitis C Market Forecast, HCV Drugs Clinical
Trials, Hepatitis C Pipeline Drugs Sales
Forecast Worldwide

• Hepatitis C Pipeline Drugs Clinical Trials
  (Drugs in Phase III) (Chapter No. 5)
• Simeprevir (TMC 435) (Company Janssen
  Pharmaceutical)
• Faldaprevir (BI 201335) (Company Boerhinger
  Ingelheim)
• Asunaprevir (BMS-650032) (Company Bristol-Myers
  Squibb)
• PEG-Interferon Lambda (Company Bristol-Myers
  Squibb)
• Sofosbuvir (PSI-7977 or GS-7977) (Company
  Gilead Sciences)
• Daclatasvir (BMS-790052) (Company Bristol-Myers
  Squibb)
• BI-207127 (Company Boerhinger Ingelheim)
• ABT-450/r (Ritonavir) (Company Abbott
  Laboratories)
• ABT-267 (Company Abbott Laboratories)
• ABT-072/333 (Company Abbott Laboratories)
• Alisporivir (Company Novartis)
• Hepatitis C Pipeline Drugs Clinical Trials
  (Drugs in Phase II) (Chapter No. 6)
• Mericitabine (RG-7128) (Company Roche)
• Danoprevir/r (Ritonavir) (RG7227) (Company
  Roche)
• GS-9256 (Company Gilead Sciences)
• GS-9451 (Company Gilead Sciences)
• MK-5172 (Company Merck)

Inquire Before Buying this report _at_
http//www.lifescienceindustryresearch.com/inquire
-before-buying?rname14764 .
5
Hepatitis C Market Forecast, HCV Drugs Clinical
Trials, Hepatitis C Pipeline Drugs Sales
Forecast Worldwide

• Hepatitis C Pipeline Drugs Clinical Trials
  (Drugs in Phase II) (Chapter No. 6)
• ACH-3102 (Company Achillion Pharmaceuticals,
  Inc)
• IDX-719 (Company Idenix)
• PPI-668 (Company Presidio Pharmaceuticals)
• Setrobuvir (ANA-598) (Company Roche)
• VX-222 (Company Vertex Pharmaceuticals)
• GS-9669 (Company Gilead Sciences)
• GS-9190 (Tegobuvir) (Company Gilead Sciences)
• BMS-791325 (Company Bristol-Myers Squibb)
• Hepatitis C Pipeline Drugs Sales Forecast
  (Chapter 7)
• Simeprevir (TMC 435)
• Faldaprevir (BI 201335) (Boerhinger Ingelheim)
• Asunaprevir (BMS-650032)
• Sofosbuvir (PSI-7977 or GS-7977)
• Daclatasvir (BMS-790052)
• ABT-450/r (Ritonavir)
• ABT-072/333
• Alisporivir

6
Hepatitis C Market Forecast, HCV Drugs Clinical
Trials, Hepatitis C Pipeline Drugs Sales
Forecast Worldwide

• Hepatitis C Pipeline Drugs Sales Forecast
  (Chapter 7)
• VX-222
• GS-9190 (Tegobuvir)
• BMS-791325
• Data Sources
• This report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by Renub
  Research team of industry experts.
• Primary sources include industry surveys and
  telephone interviews with industry experts.
• Secondary sources information and data has been
  collected from various printable and
  non-printable sources like search engines, News
  websites, Government Websites, Trade Journals,
  White papers, Government Agencies, Magazines,
  Newspapers, Trade associations, Books, Industry
  Portals, Industry Associations and access to more
  than 500 paid databases.

7
About us Life Science Industry
Research brings to you to the latest reports in
market research on Biotechnology, Diagnostics,
Healthcare, Medical Devices and Pharmaceuticals
segments from leading research publishers across
the globe. These reports also cover data and
information on sub-segments and sectors under
these life sciences categories.Contact us
(sales_at_lifescienceindustryresearch.com / 1 888
391 5441) for any of your research requirements
or topics of interest. Our sales research
associates will be happy to help you find
relevant market data.Website
www.lifescienceindustryresearch.com
Browse Latest Industry News, Updates, Trends,
Opportunities, Scenario all over the world _at_